(+/-)-7-(4-(22-(2-allylphenoxy)-21-hydroxy-2,9-dioxo-13,16-dioxa-3,10,19-triazadocosyloxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (+/-)-7-(4-(22-(2-allylphenoxy)-21-hydroxy-2,9-dioxo-13,16-dioxa-3,10,19-triazadocosyloxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(+/-)-7-(4-(22-(2-allylphenoxy)-21-hydroxy-2,9-dioxo-13,16-dioxa-3,10,19-triazadocosyloxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Beta-3 adrenergic receptor Protein (Entity type)	Kd
(+/-)-7-(4-(22-(2-allylphenoxy)-21-hydroxy-2,9-dioxo-13,16-dioxa-3,10,19-triazadocosyloxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Beta-1 adrenergic receptor Protein (Entity type)	Kd
(+/-)-7-(4-(22-(2-allylphenoxy)-21-hydroxy-2,9-dioxo-13,16-dioxa-3,10,19-triazadocosyloxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Beta-2 adrenergic receptor Protein (Entity type)	Kd